Pulmonx Corp (LUNG) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated March 2, 2026, details a material definitive agreement entered into by Pulmonx Corporation. The filing announces the execution of a new senior secured term loan facility and the concurrent termination of a prior credit agreement with the Canadian Imperial Bank of Commerce (CIBC).
Key Financial Metrics and Transaction Details
- Debt Facility: Entered into a Credit Agreement with Perceptive Credit Holdings V, LP for a total facility of up to $60.0 million.
- Initial Draw: Borrowed $40.0 million on the closing date (March 2, 2026).
- Delayed Draws: Up to an additional $20.0 million available in two $10.0 million tranches contingent on revenue milestones ($92.5 million and $100.0 million trailing twelve-month revenue).
- Interest Rate: One-month term SOFR (or 3.75% floor) plus a 7.00% applicable margin. Up to 2.00% of the margin may be paid-in-kind (PIK) for the first 36 months.
- Maturity: March 2, 2031, with no scheduled principal payments prior to maturity.
- Fees: $750,000 upfront fee (1.25% of total facility) and a 1.50% exit fee upon repayment.
- Equity Component: Issued warrants to purchase 1,000,000 shares at $1.92 per share (25% premium to VWAP). Additional warrants will be issued upon funding of delayed tranches.
- Covenants: Requires maintaining minimum liquidity of $4.0 million and meeting specific revenue thresholds.
Material Changes Versus Prior Period
The Company terminated its Amended and Restated Loan and Security Agreement with the Canadian Imperial Bank of Commerce, repaying all outstanding indebtedness under that facility. No early termination fees or penalties were incurred. This transaction replaces the CIBC facility with the new Perceptive Credit Facility, altering the Company's debt structure, interest rate profile, and collateral requirements.
Outlook, Risks, and Contingencies
- Revenue Contingency: Access to the remaining $20.0 million of the credit facility is strictly contingent on achieving specific revenue targets by fiscal quarters ending in 2027.
- Default Risks: An event of default could trigger an automatic increase in the applicable margin by 3.00% and acceleration of all outstanding principal and interest.
- Collateral: The new debt is secured by a first-priority security interest on substantially all existing and after-acquired assets of the Company and its subsidiaries.
- Prepayment Penalties: Prepayment prior to the fourth anniversary of the closing date is subject to a premium ranging from 2% to 10%.
Investor Verification Checklist
- Verify the Company's current liquidity position to ensure compliance with the $4.0 million minimum liquidity covenant.
- Review the Company's revenue trajectory to assess the likelihood of triggering the $92.5 million and $100.0 million milestones required for additional funding.
- Confirm the impact of the 7.00% margin plus SOFR (with PIK option) on future interest expense and cash flow projections.
- Assess the dilution impact of the initial 1,000,000 warrants and potential additional warrants if delayed tranches are drawn.
- Examine the full text of the Credit Agreement (Exhibit 10.1) for specific definitions of "Revenue" and "Liquidity" used in the covenants.